Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?

Jakob Wested, Timo Minssen, Esther Van Zimmeren

    Abstract

    As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal.
    OriginalsprogEngelsk
    TidsskriftLife Sciences Intellectual Property Review (LSIPR)
    Udgave nummer13/7 2018
    Antal sider6
    StatusUdgivet - 13 jul. 2018

    Emneord

    • Det Juridiske Fakultet

    Adgang til dokumentet

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?'. Sammen danner de et unikt fingeraftryk.
    Se fuldt fingeraftryk
    • 1 Foredrag og mundtlige bidrag

    Citationsformater